A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Clinical trial NCT07572006 · RECRUITING

Trial details

NCT number: NCT07572006
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2026-05-13
Primary completion: 2029-05-18
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.